홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
RIGL
#2824
Rigel Pharmaceuticals Inc. (New)
31.390
0
USD
+4.74%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+4.74%
월간 변동
+18.36%
6달 변화
+4.18%
년간 변동율
+4.18%
이전 종가
29.970
0
Open
31.390
0
Bid
Ask
Low
31.390
0
High
31.390
0
양
53
마켓
주식
헬스케어
RIGL
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
17 M
17.17 M
17.37 M
17.54 M
17.86 M
18.47 M
—
Valuation ratios
Enterprise value
604.07 M
456.83 M
249.21 M
283.55 M
303.99 M
803.52 M
2.01 B
Price to earnings ratio
—
-24.09
-3.94
-10.43
16.99
2.2
18.83
Price to sales ratio
—
3.03
1.92
2.17
1.66
2.74
7.41
Price to cash flow ratio
—
76.86
-3.13
-44.24
9.45
10.67
32.32
Price to book ratio
—
14.87
-16.97
-8.87
90.48
2.06
-5.29
EBITDA 비율에 대한 기업 가치
-19.98
-30.85
-3.72
-10.74
9.99
5.98
19.18
Profitability ratios
Return on assets %
-0.27
-0.11
-0.44
-0.21
0.11
0.71
0.99
Return on equity %
-0.87
-0.59
4.3
0.88
5.32
0.94
2.27
Return on invested capital %
-167.5
-90.01
-299.96
-164.29
155.66
736.83
959.1
Gross margin %
99.18
99.27
98.55
93.92
89.6
93.33
371.93
Operating margin %
-26.67
-8.37
-46.2
-17.53
13.49
42.63
158.15
EBITDA margin %
-26.02
-9.47
-46.6
-17.78
13.61
42.64
170.9
Net margin %
-27.38
-12
-48.71
-21.47
9.75
124.72
504.29
Liquidity ratios
Quick ratio
2.14
2.33
1.64
1.76
2.04
2.3
8.47
Current ratio
2.18
2.43
1.78
1.86
2.13
2.42
8.92
Inventory turnover
0.6
0.26
0.22
0.97
3.24
2.24
2.31
Asset turnover
0.84
1.07
0.8
0.93
1.28
0.87
1.34
Solvency ratios
Debt to assets ratio
0.36
0.12
0.31
0.51
0.37
0.1
0.99
Debt to equity ratio
1.15
0.68
-3.01
-2.1
18.33
0.14
4.67
Long term debt to total assets ratio
0.18
0.12
0.3
0.51
0.37
0.1
0.98
Long term debt to total equity ratio
0.59
0.66
-2.94
-2.09
18.25
0.13
4.61
Per share metrics
Operating cash flow per share
—
0.34
-4.28
-0.33
1.78
4.02
4.05
EBIT per share
—
-0.73
-3.22
-1.18
1.37
6.66
6.78
EBITDA per share
—
-0.83
-3.25
-1.19
1.38
6.66
7.25
Total debt per share
—
1.22
2.38
3.46
3.41
2.81
12.66
Cash per share
—
7.33
3.38
3.27
4.37
8.23
25.61
Net current asset value per share
—
9.06
6.72
5.7
7.64
12.75
41.69
Tangible book value per share
—
1.78
-1.66
-2.44
-1.35
19.47
26.93
Working capital per share
—
5.33
2.94
2.64
4.06
7.48
23.06
Book value per share
—
1.78
-0.79
-1.65
0.19
20.78
32.45
뉴스
Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (NASDAQ:RIGL)
Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?
Micron and Coinbase among market cap stock movers on Wednesday
Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript
Rigel, 연간 60% 성장, 유망한 MDS 데이터 발표
Rigel Q4 2025 slides: 60% annual growth, promising MDS data
Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates
X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval
Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan
Implied Volatility Surging for Rigel Pharmaceuticals Stock Options
Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline
Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates